Gen1E Lifesciences

Gen1E Lifesciences is a developer of a platform aimed at accelerating the treatment of inflammatory and age-related diseases. The company’s services include a range of preclinical stage products, including P38 kinase inhibitors for treating various inflammations, enabling medical researchers to optimize existing regulatory incentives, reduce required R&D time and costs, shorten time to exit, and increase the likelihood of FDA approval and commercial success.